Clinical Trial Update: A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced

View source ↗

Summary

A ClinicalTrials.gov study sponsored by MSD Italia aims to describe how patients with early-stage and locally advanced non-small cell lung cancer are diagnosed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: MSD Italia S.r.l. | Conditions: Non-small Cell Lung Cancer, NSCLC | Status: RECRUITING